Figure 2.

Overall survival, Kaplan-Meier survival estimate. (A) Liver only versus multiple metastatic sites; (B) liver-only versus multiple metastatic sites, KRAS wild-type; (C) liver-only versus multiple metastatic sites, KRAS mutant. 1, Progression-free survival; 2, overall survival.

Bruera et al. BMC Medicine 2012 10:135   doi:10.1186/1741-7015-10-135
Download authors' original image